| May 25, 2023 |
Adamis Pharmaceuticals Announces Closing of the Merger with DMK Pharmaceuticals
|
|
| May 19, 2023 |
Adamis Pharmaceuticals Announces Reverse Stock Split
|
|
| May 15, 2023 |
Adamis Pharmaceuticals Reports First Quarter 2023 Financial Results and Provides Corporate Update
|
|
| May 08, 2023 |
Adamis Pharmaceuticals Schedules First Quarter 2023 Financial Results Conference Call and Corporate Update
|
|
| Mar 16, 2023 |
Adamis Pharmaceuticals Reports Full Year 2022 Financial Results and Provides Corporate Update
|
|
| Mar 14, 2023 |
Adamis Pharmaceuticals Schedules Fourth Quarter and Full Year 2022 Financial Results Conference Call and Corporate Update
|
|
| Mar 14, 2023 |
Adamis Pharmaceuticals Announces $3.0 Million Registered Direct Offering
|
|
| Feb 27, 2023 |
Adamis Pharmaceuticals and DMK Pharmaceuticals Announce Agreement and Plan of Merger
|
|
| Feb 22, 2023 |
Nasdaq Grants Adamis Pharmaceuticals’ Request for Extension to Comply with Continued Listing Requirements
|
|